TITLE

Manufacturers remain at odds on patent reform

AUTHOR(S)
Bogardus, Kevin
PUB. DATE
May 2009
SOURCE
Hill;5/21/2009, Vol. 16 Issue 59, p14
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports on the issue concerning the potential of manufacturers and pharmaceutical representatives to postpone controversial changes to U.S. patent laws.
ACCESSION #
40541636

 

Related Articles

  • Ranbaxy's woes add $900 million in costs for heart drug in US.  // FRPT- FMCG Snapshot;4/20/2014, p21 

    The article reports that the delayed entry of pharmaceutical company Ranbaxy Laboratories Ltd. to manufacture and market copies of the heart drug Diovan manufactured by drug maker Novartis AG, due to a gap in U.S. patent law, has cost U.S. consumers and insurers as much as 900 million U.S....

  • A LOOK AT GOVERNMENT IMPACT ON THE REPAIR INDUSTRY. Yoswick, John // Dixie Automotive Report;Apr2014, Vol. 23 Issue 1, p4 

    The article reflects on the proposed policies that U.S. legislators are considering around the country and in Washington D.C. and how it can affect business. Topics discussed include a proposed legislation that would cut original equipment manufacturer (OEM) patents, bills introduced in...

  • PATENT ENFORCEMENT UNDER SECTION 337 BEFORE THE UNITED STATES INTERNATIONAL TRADE COMMISSION: EVOLUTION OF THE FORUM TO ADDRESS A NON-MANUFACTURING MARKETPLACE. Sterne, Robert Greene; Yonan, Daniel E.; Specht, Michael D.; Frueauf, Jeremiah B. // Sedona Conference Journal;Sep2011, Vol. 12, p2011 

    The article focuses on the reason why Section 337 before the U.S. International Trade Commission will be the most important developing areas in the U.S. patent law. The authors state that research and development are superseding manufacturing as the high technology output of innovation. They...

  • Today in History.  // Adirondack Daily Enterprise;4/10/2010, Vol. 117 Issue 86, pA5 

    The article provides an account of historical happenings worldwide from April 10, 1912 to April 10, 2009 which include the passage of the first U.S. Patent Act in 1790, the publication of F. Scott Fitzgerald's novel "The Great Gatsby," in 1925, the reopening of the Suez Canal in 1957 in Egypt,...

  • Zone in on: Regulation. Ritter, Amy // Pharmaceutical Technology;May2011, Vol. 35 Issue 5, p22 

    The article reports on the amendment of the Patent Act of 1952 in the U.S.

  • EXTENDING PROVISIONAL PATENTS…SORT OF.  // Inventors' Digest;Jun2010, Vol. 26 Issue 6, p17 

    The article reports that the U.S. Patent and Trademark Office (USPTO) has announced on April 2, 2010 the proposed change in its non-provisional application Missing Parts practice, with the net effect of extending the provisional patent period.

  • REVITALIZING THE PATENT SYSTEM TO INCENTIVIZE PHARMACEUTICAL INNOVATION: THE POTENTIAL OF CLAIMS WITH MEANS-PLUS-FUNCTION CLAUSES. WANLI (LILY) TANG // Duke Law Journal;Feb2013, Vol. 62 Issue 5, p1069 

    The pharmaceutical industry relies on innovation. However, many innovative firms are cutting their research and development investments and seeing their new product pipelines dry up, due in part to a lack of sufficient patent protection. This Note identifies two major factors that have caused...

  • Associations see legislative prospects as mixed for 2010. McCARTY, MARK // Medical Device Daily;1/11/2010, Vol. 14 Issue 6, p1 

    The article focuses on the views of the Medical Device Manufacturers Association (MDMA) and the Advanced Medical Technology Association (AdvaMed) on the health care reform bill in the U.S. for 2010. The associations claim that the proposed patent reform legislation is not encouraging. The views...

  • Broadening Design Patents to Disclaim Subject Matter: How Little Is Too Much? Phelps, Michael P. F. // Federal Lawyer;Aug2013, Vol. 60 Issue 7, p12 

    The article focuses on the efforts of the U.S manufacturers in obtaining design patents that claim or disclaim the product's overall design and the its individual elements. Topics discussed include the approach of the U.S Patent and Trademark Office (PTO) on written description requirement under...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics